The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy

PACE - Pacing and Clinical Electrophysiology

Volumn 21, Issue 1 II, 1998, Pages 299-302

  Zhu, Dennis W X ^a   Sun, Huabin ^a   Hill, Rita ^a   Roberts, Robert ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Electrophysiology study; Hypertrophic cardiomyopathy; Implantable cardioverter defibrillator; Sudden death

Indexed keywords

ADOLESCENT; ADULT; AGED; CARDIOVERSION; CONFERENCE PAPER; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE SEPTUM; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE RESECTION; SCHOOL CHILD; SUDDEN DEATH; SYNCOPE;

ADULT; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; PROGNOSIS; RISK ASSESSMENT; SYNCOPE; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 0031882573     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1998.tb01109.x     Document Type: Article

References (6)

1. McKenna WJ, Goodwin JF. The natural history of hypertrophic cardiomyopathy. In Harvey P (ed.): Current Problems in Cardiology. Chicago, Year Book Medical Publishers, 1981, vol VI, pp 5-26.
2. Borggrefe M, Chen X, Block M, et al. The role of the ICD in patients with dilated and hypertrophic cardiomyopathy. PACE 1992; 15:616-626.
3. Kuck K-H, Kunze K-P, Schluter M, et al. Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. Euro Heart J 1988; 9:177-185.
4. Lechin M, Quinones MA, Omran A, et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995;92:1808-1812.
5. Fananapazir L, Chang AC, Epstein SE, et al. Prognostic determinants in hypertrophic cardiomyopathy: Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation 1992;86:730-740.
6. Watson RM, Schwartz JL, Maron BJ, et al. Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death. JACC 1987;10:761-774.